Cidara Therapeutics names Jim Beitel CBO

Cidara Therapeutics announced that Jim Beitel, MBA, has joined the company as its Chief Business Officer. Following recent transactions, Cidara is focused exclusively on advancing its Cloudbreak DFC pipeline, which provides numerous partnering and licensing opportunities, and a dedicated CBO will be a vital resource for the organization. Preetam Shah, Ph.D., MBA, who has held the roles of both Chief Financial Officer and CBO for Cidara since 2021, will continue as the CFO and principal accounting officer overseeing the finance, accounting, and investor relations functions. “We welcome Jim to Cidara’s executive team during an important time of corporate transformation,” said Jeffrey Stein, Ph.D., President and Chief Executive Officer of Cidara. “Jim’s extensive expertise in biopharma business development and partnerships will be extremely valuable given the expansive partnering opportunities created by our Cloudbreak pipeline starting with CD388, our universal influenza preventative, entering a Phase 2b trial this fall. I am confident that he will be a tremendous asset to the Company.”